Wang L, Pitts D K
Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, Wayne State University, Detroit, Michigan.
J Pharmacol Exp Ther. 1995 Jan;272(1):164-76.
This study characterized somatodendritic dopamine (DA) autoreceptors on nigral DA-containing neurons during postnatal developmental in chloral hydrate-anesthetized rats. Antidromically activated nigrostriatal DA (NSDA) neurons from 2-week-old animals were found to be less sensitive to the inhibitory effects of cumulative i.v. doses (1-32 micrograms/kg) of the DA agonists apomorphine (D2/D3/D1) and quinpirole (D2/D3) than those from adults. The age-dependent difference in DA agonist sensitivity was found to be of significantly greater magnitude for apomorphine than for quinpirole. When a single i.p. dose (64 micrograms/kg) of apomorphine that elicits a moderate level of inhibition was administered, however, no significant differences between the sensitivity of 2-week-old and adult NSDA neurons were found. In iontophoretic studies, no age-dependent (1, 2 and 4 week-olds and adults) differences in nigral DA neuron sensitivity to the inhibitory effects of apomorphine, quinpirole and the D3/D2 agonist, 7-hydroxy-dipropylaminotetralin HBr were found. Iontophoretic studies with the DA antagonists, eticlopride (D2/D3) and 7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (D1), and i.v. studies with the DA agonists 1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol (D1) and N-allyl-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol (D1) indicate that somatodendritic DA autoreceptors on 2-week-old NSDA neurons appear to be of the D2/D3 subtype. These results suggest that functional adult-like somatodendritic DA autoreceptors are present on nigral DA neurons during early postnatal development. Given the conflict between the iontophoretic and i.v. results, however, the nature of any potential age-dependent differences in somatodendritic autoreceptor sensitivity to DA agonists will need to be examined further in vitro.
本研究对水合氯醛麻醉的大鼠出生后发育过程中黑质含多巴胺(DA)神经元上的树突体DA自身受体进行了表征。研究发现,与成年动物相比,2周龄动物经逆向激活的黑质纹状体DA(NSDA)神经元对累积静脉注射剂量(1 - 32微克/千克)的DA激动剂阿扑吗啡(D2/D3/D1)和喹吡罗(D2/D3)的抑制作用不太敏感。DA激动剂敏感性的年龄依赖性差异在阿扑吗啡方面比喹吡罗显著更大。然而,当给予单次腹腔注射剂量(64微克/千克)的阿扑吗啡并引发中等程度的抑制时,未发现2周龄和成年NSDA神经元的敏感性存在显著差异。在离子电泳研究中,未发现黑质DA神经元对阿扑吗啡、喹吡罗和D3/D2激动剂7 - 羟基 - 二丙基氨基四氢溴化萘的抑制作用的敏感性存在年龄依赖性(1、2和4周龄以及成年)差异。使用DA拮抗剂依托必利(D2/D3)和7 - 氯 - 8 - 羟基 - 3 - 甲基 - 1 - 苯基 - 2,3,4,5 - 四氢 - 1H - 3 - 苯并氮杂卓(D1)的离子电泳研究以及使用DA激动剂1 - 苯基 - 2,3,4,5 - 四氢 - (1H) - 3 - 苯并氮杂卓 - 7,8 - 二醇(D1)和N - 烯丙基 - 1 - 苯基 - 2,3,4,5 - 四氢 - (1H) - 3 - 苯并氮杂卓 - 7,8 - 二醇(D1)的静脉注射研究表明,2周龄NSDA神经元上的树突体DA自身受体似乎是D2/D3亚型。这些结果表明,在出生后早期发育过程中,黑质DA神经元上存在功能类似成年的树突体DA自身受体。然而,鉴于离子电泳和静脉注射结果之间存在冲突,树突体自身受体对DA激动剂的任何潜在年龄依赖性差异的性质需要在体外进一步研究。